コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Patients with low body weight had the worst prognosis.
2 ts who bear a large disease burden and carry the worst prognosis.
3 ncrease (>0 kPa/year) in >/= 14 kPa bLSM had the worst prognosis.
4 tor-cell gene expression are associated with the worst prognosis.
5 nosis, whereas a GPA of 0.0 corresponds with the worst prognosis.
6 nes associated with proteasomal activity and the worst prognosis.
7 r recurrent RPS; Patients with >7 tumors had the worst prognosis.
8 survival, together distinguishing cases with the worst prognosis.
9 cancer is one of the malignant diseases with the worst prognosis.
10 , and Arg282) in the DNA-binding domains had the worst prognosis.
11 y more effective treatments to patients with the worst prognosis.
12 pies in the treatment of those patients with the worst prognosis.
13 imated by plasma norepinephrine levels, have the worst prognosis.
14 P<0.001), and patients with >5 criteria had the worst prognosis.
15 er iCMS2 or iCMS3 epithelium; the latter had the worst prognosis.
16 showed that the double-negative subtype has the worst prognosis.
17 ointestinal, but intracranial hemorrhage has the worst prognosis.
18 s for 10-30% of strokes, being the form with the worst prognosis.
19 c instability and are among the tumours with the worst prognosis.
20 ly aggressive form of pancreatic cancer with the worst prognosis.
21 in or progressed to stage E by 24 hours had the worst prognosis.
22 ions, high expression of VEGF receptor 2 and the worst prognosis.
23 of a H3K27M mutation (K27M), associated with the worst prognosis.
24 he most aggressive type of breast tumor with the worst prognosis.
25 Typically, fungal ulcers carry the worst prognosis.
26 gressive subtype of breast cancer leading to the worst prognosis.
27 red in the first week), and Hispanics showed the worst prognosis (0.3% recovered at 1 week) (P=0.0001
29 isk strata of TRVol >=45 ml or TRF >=50% had the worst prognosis (AHR: 2.26; 95% CI: 1.36 to 3.76; p
30 ancreatic cancer is a deadly disease and has the worst prognosis among almost all cancers and is in d
31 Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among major cancer types, primarily
33 lofibrosis) is a deadly blood neoplasia with the worst prognosis among myeloproliferative neoplasms (
34 Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among solid malignancies and improve
35 -negative breast cancer (TNBC) patients have the worst prognosis and distant metastasis-free survival
37 hemorrhage (ICH) is the stroke subtype with the worst prognosis and has no established acute treatme
38 pe is among the most aggressive cancers with the worst prognosis and least therapeutic targetability
40 ur positive nodes and PR-negative tumors had the worst prognosis, and those treated with tamoxifen pl
47 her IgA isotype or unfavorable karyotype had the worst prognosis (EFS, < or = 10 months; median OS, <
48 positive/polysomy 17 patients tended to have the worst prognosis, followed by HER2-positive/eusomic,
49 atic decompensation identifies patients with the worst prognosis following AB and is more common in p
50 gh Met expression in cancer cells speculates the worst prognosis for patients with invasive breast ca
57 is observed in chemical injury eyes, whereas the worst prognosis is in aniridia, although the latter
59 Triple-negative breast cancer (TNBC) has the worst prognosis of all breast cancers, and women dia
62 ive breast cancer (TNBC), which also carries the worst prognosis of all forms of breast cancer; there
65 t of the heart (cardiac amyloidosis) carries the worst prognosis of any involved organ, and light-cha
66 OPN and CD44 overexpression correlate with the worst prognosis of human gastroesophageal carcinoma.
67 but did not undergo splenectomy demonstrated the worst prognosis on multivariate analysis independent
68 pment of a second malignancy was 38.1%, with the worst prognosis seen after acute leukemia and lung c
70 ke type includes diffuse-subtype tumors with the worst prognosis, the tendency to occur at an earlier
75 model in which patients with high-CK exhibit the worst prognosis, whereas those with mutated CLL lack